Global Oral Medicines for Diabetes Supply, Demand and Key Producers, 2023-2029

Global Oral Medicines for Diabetes Supply, Demand and Key Producers, 2023-2029

The global Oral Medicines for Diabetes market size is expected to reach $ 124450 million by 2029, rising at a market growth of 10.2% CAGR during the forecast period (2023-2029).

Oral medications for diabetes are medications that are taken by mouth to manage blood sugar levels in people with type 2 diabetes.

This report studies the global Oral Medicines for Diabetes production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Oral Medicines for Diabetes, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oral Medicines for Diabetes that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Oral Medicines for Diabetes total production and demand, 2018-2029, (K Units)

Global Oral Medicines for Diabetes total production value, 2018-2029, (USD Million)

Global Oral Medicines for Diabetes production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Oral Medicines for Diabetes consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Oral Medicines for Diabetes domestic production, consumption, key domestic manufacturers and share

Global Oral Medicines for Diabetes production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Oral Medicines for Diabetes production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Oral Medicines for Diabetes production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global Oral Medicines for Diabetes market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Merck, Novartis, Huadong Medicine, Sanofi, Novo Nordisk, Servier, Takeda Pharmaceutical and Luye Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oral Medicines for Diabetes market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Oral Medicines for Diabetes Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Oral Medicines for Diabetes Market, Segmentation by Type
Biguanides
Sulfonylureas
Meglitinides
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
SGLT2 Inhibitors
Thiazolidinediones
Alpha-Glucosidase Inhibitors
Other

Global Oral Medicines for Diabetes Market, Segmentation by Application
Hospital
Clinic
Other

Companies Profiled:
Bayer
Merck
Novartis
Huadong Medicine
Sanofi
Novo Nordisk
Servier
Takeda Pharmaceutical
Luye Pharmaceutical
Taiji Group
CR Double-Crane
AstraZeneca
Boehringer Ingelheim
Qilu Pharmaceutical
Jiangsu Deyuan Pharmaceutical
CTTQ

Key Questions Answered

1. How big is the global Oral Medicines for Diabetes market?

2. What is the demand of the global Oral Medicines for Diabetes market?

3. What is the year over year growth of the global Oral Medicines for Diabetes market?

4. What is the production and production value of the global Oral Medicines for Diabetes market?

5. Who are the key producers in the global Oral Medicines for Diabetes market?

6. What are the growth factors driving the market demand?